Yazar "Onaran, Y." seçeneğine göre listele
Listeleniyor 1 - 4 / 4
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe ADAM9, ADAM10 and ADAM17 differentially regulated in male infertility(Wiley-Blackwell, 2016) Guven, K. N.; Bayram, N. A.; Pekel, A.; Yildirim, M. E.; Duvan, C. Iltemir; Cimentepe, E.; Onaran, Y.[Abstract Not Available]Öğe Benefits of the Neutrophil-to-Lymphocyte Ratio for the Prediction of Gestational Diabetes Mellitus in Pregnant Women(Johann Ambrosius Barth Verlag Medizinverlage Heidelberg Gmbh, 2014) Yilmaz, H.; Celik, H. T.; Namuslu, M.; Inan, O.; Onaran, Y.; Karakurt, F.; Ayyildiz, A.Aims: There is growing consensus in the literature that inflammation plays a central role in the pathophysiology of obesity, Type 2 Diabetes Mellitus (T2DM), Gestational Diabetes Mellitus (GDM) and cardiovascular complications. Measuring the neutrophil-to-lymphocyte ratio (NLR) provides a simple inexpensive method for the assessment of inflammatory status. We investigated the predictive value of pre-procedural (before the oral glucose tolerance test (OGTT)) NLR on the development of GDM in pregnancy. Methods: 42 women with GDM and 68 women without GDM were included in the study. Complete Blood Count and biochemical tests were followed by a diagnostic 4-point 100-g-OGTT within 2 weeks. GDM was diagnosed by the Carpenter and Coustan criteria. The NLR was calculated from the data. Results: The mean NLR level was significantly higher in GDM women (3.00 +/- 0.83 vs. 2.26 +/- 0.43 p < 0.001, respectively). In ROC analysis, NLR > 2.93 had 76.2 % sensitivity and 94.1 % specificity in predicting GDM. Logistic regression analysis showed that elevated NLR (OR: 5.512, 95 % CI: 1.352-22.475, p = 0.017) was an independent variable for predicting GDM in pregnancy. Conclusions: An elevated NLR level is a powerful and independent predictor of GDM. The results of this study suggested that inflammation plays a central role in the pathogenesis of GDM.Öğe DOES ETONOGESTREL CONTRACEPTIVE IMPLANT (IMPLANON) EFFECT BONE METABOLISM DURING LACTATION PERIOD?(Elsevier Science Inc, 2013) Duvan, C. Iltemir; Onaran, Y.; Keskin, E. Aktepe; Yanik, B.; Kafali, H.; Turhan, N. Ozturk[Abstract Not Available]Öğe DOES IGNORING OF THE THE GnRH-ANTAGONISTS ON THE DAY OF hCG EFFECT CYCLE OUTCOME DURING GnRH-ANTAGONIST PROTOCOL?(Elsevier Science Inc, 2013) Duvan, C. Iltemir; Onaran, Y.; Ayrim, A.; Pekel, A.; Kafali, H.; Turhan, N. Ozturk[Abstract Not Available]












